Dmitry Goldenberg is a Partner in Simon-Kucher’s global Healthcare & Life Sciences sector and based in the New York City office. He has nearly two decades of experience across the consulting and pharmaceutical industry helping companies develop pricing, market access, and commercial strategy. Dmitry specializes in multiple areas, including:
- Global and US Access, Pricing, and Reimbursement Strategy
- Commercial Strategy and Market Development
- Lifecycle Management and Portfolio Strategy
- Innovative Pricing & Contracting Strategy
Dmitry joined Simon-Kucher after more than 5 years at Pfizer as a member of the Oncology Global Access Strategy & Pricing team, where he developed market access strategy for the breast cancer franchise and led multiple organizational readiness initiatives. During his time at Pfizer, he developed global pricing strategy for multiple brands, created access and commercial brand deliverables, and partnered with more than 40 countries around the world to support payer negotiations.
Prior to joining Pfizer, Dmitry was a Principal in Decision Resources Group’s Consulting division, where he was a member of the leadership team and focused on helping pharmaceutical companies develop US managed care strategy, including pricing, contracting, and reimbursement.
Dmitry has supported clients across all stages of the product lifecycle and has launched products in oncology, rare & orphan diseases, diabetes, and cardiology therapeutic areas. He uses his unique blend of consulting and pharmaceutical industry experience to develop access and commercial strategies that can improve patient outcomes around the world.